Brentuximab vedotin: axonal microtubule's Apollyon

Blood Cancer J. 2015 Aug 28;5(8):e343. doi: 10.1038/bcj.2015.72.

Authors

S Mariotto¹, S Ferrari¹, M Sorio², F Benedetti², G Tridente³, T Cavallaro¹, A Gajofatto¹, S Monaco¹

Affiliations

¹ Department of Neurological and Movement Sciences, University of Verona, Verona, Italy.
² Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy.
³ School of Medicine, University of Verona, Verona, Italy.

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Autografts
Brentuximab Vedotin
Chemoradiotherapy
Hodgkin Disease / therapy*
Humans
Immunoconjugates / adverse effects*
Immunoconjugates / therapeutic use
Male
Peripheral Nervous System Diseases / chemically induced
Peripheral Nervous System Diseases / diagnosis*
Stem Cell Transplantation
Tubulin Modulators / adverse effects*
Tubulin Modulators / therapeutic use
Young Adult

Substances

Immunoconjugates
Tubulin Modulators
Brentuximab Vedotin